Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) shares rose 4.3% during mid-day trading on Monday . The stock traded as high as $16.44 and last traded at $16.17. Approximately 38,413 shares were traded during trading, a decline of 53% from the average daily volume of 82,291 shares. The stock had previously closed at $15.51.
Gyre Therapeutics Price Performance
The business has a fifty day moving average of $17.58.
Gyre Therapeutics Company Profile
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Featured Stories
- Five stocks we like better than Gyre Therapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Technologies to Challenge NAND Flash Dominance in AI
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Is Zoom Video Stock Getting Too Cheap to Pass Up?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Packaging Corporation of America: Buy The Dip
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
